30 results for «1220»
30 results
EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on stent technology
17 May 2023 – From EuroPCR 2023
If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...
Highlights in valvular heart disease research - The year in EuroIntervention
17 Nov 2025 – From PCR London Valves 2025
This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system...
TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.
Welcome and introduction to PCR Innovators Day London
24 Sep 2017 – From PCR Innovators Day 2017
EuroPCR 2017 Closing Ceremony
19 May 2017 – From EuroPCR 2017
PCR London Valves Opening Ceremony
18 Nov 2019 – From PCR London Valves 2019
Consult this session on PCR London Valves, a patient-oriented course for all of the heart valve team, to discover the 2019 Opening Ceremony, led by Jean Fajadet: learn all about the course program, and how it will enhance your clinical practice.
Major Late-Breaking Trials from EuroPCR 2024
15 May 2024 – From EuroPCR 2024
This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...
Asymptomatic severe aortic stenosis: Will these trials change my practice?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...
Predicting and managing TAVI conduction related disorders
20 May 2022 – From EuroPCR 2022
Get key learnings on conduction disorders after TAVI, the role of temporary pacing devices and different strategies to reduce permanent pacemaker implants to the minimum.
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
- ← previous
- 1
- 2
- next →